Filing Flows › National Healthcare (NHC) › Stock forecast & fair value
National Healthcare (NHC) stock forecast and fair value
National Healthcare (NHC) trades at $208.85. Across 28 valuation methods the middle fair value is $141.71 (-32%); the DCF says $127.90.
Fair value by method
| Method | Low | Point | High | vs price |
|---|---|---|---|---|
| Regime-switching Monte Carlo 10th–90th | $70.47 | $150.59 | $355.06 | -28% |
| DCF — Monte Carlo 10th–90th percentile | $74.61 | $127.90 | $203.80 | -39% |
| P/E vs peers | $120.01 | $179.15 | $219.01 | -14% |
| P/E vs peers, weighted | $100.02 | $136.50 | $198.24 | -35% |
| P/E vs peers, matched | $118.41 | $184.69 | $228.21 | -12% |
| P/E vs peers, growth-adjusted | $97.40 | $139.15 | $198.78 | -33% |
| EV/EBITDA vs peers | $138.68 | $165.88 | $273.02 | -21% |
| EV/EBITDA vs peers, weighted | $87.48 | $159.55 | $183.93 | -24% |
| EV/EBITDA vs peers, matched | $132.69 | $159.72 | $249.74 | -24% |
| EV/EBITDA vs peers, growth-adjusted | $105.18 | $154.35 | $221.71 | -26% |
National Healthcare's latest quarter
National Healthcare, Q3 2026: revenue $408M (+7% year over year), operating margin 10.0%, net earnings $13.6M, operating cash flow $99.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is National Healthcare's fair value?
The fair-value methods on Filing Flows (DCF, Monte Carlo, peer multiples and others) put it between $1.53 and $271.42, with a middle value of $141.71 against a price of $208.85. Each method's assumptions are on the page.
Is NHC stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.